# Preference, Satisfaction and Ease of Use of Genuair® (Pressair™) and Breezhaler® (Neohaler™) Inhalers in Patients With COPD

> **NCT01915784** · PHASE3 · COMPLETED · sponsor: **Almirall, S.A.** · enrollment: 128 (actual)

## Conditions studied

- Chronic Obstructive Pulmonary Disease (COPD)

## Interventions

- **DEVICE:** Genuair®
- **DEVICE:** Breezhaler®

## Key facts

- **NCT ID:** NCT01915784
- **Lead sponsor:** Almirall, S.A.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-07
- **Primary completion:** 2013-10
- **Final completion:** 2013-10
- **Target enrollment:** 128 (ACTUAL)
- **Last updated:** 2015-05-29

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01915784

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01915784, "Preference, Satisfaction and Ease of Use of Genuair® (Pressair™) and Breezhaler® (Neohaler™) Inhalers in Patients With COPD". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01915784. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*